Bausch + Lomb Corp
F:S2L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bausch + Lomb Corp
F:S2L
|
CA |
|
N
|
NL Development PCL
SET:NL
|
TH |
Intrinsic Value
The intrinsic value of 
Bausch + Lomb Corp (S2L) under the Base Case is 16.41 EUR per share.
Compared with the current market price of 14.1 EUR, the stock appears
Undervalued by 14% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Bausch + Lomb Does
Bausch + Lomb makes eye-care products for people who need help seeing, protecting, or treating their eyes. Its lineup includes contact lenses, lens care products, surgical devices and implants used in eye procedures, and prescription and over-the-counter eye medicines. The company sells to consumers, eye doctors, hospitals, and surgery centers, so it sits in both the everyday vision-care market and the specialist ophthalmology market.
- Headquarters
- Canada CA
- Employees
- 13 000
- IPO date
- May 6, 2022
Earnings Waterfall
Bausch + Lomb Corp
The intrinsic value for Bausch + Lomb Corp (S2L) under the Base Case is 16.41 EUR.
Compared with the current market price of 14.1 EUR, the stock appears Undervalued by 14% .